Page 1

R IG SHO SP I TALE T

Dedicated to the latest in scientific research and development www.rigshospitalet.dk


R I G S H O S P I T A L E T

59

WWW.EUROPEOUTLOOKMAG.COM


H

E

A

L

T

H

C

A

R

E

Denmark’s Medical As the flagship hospital for the capital region of Denmark, Rigshospitalet will continue in its efforts to remain the preferred choice for patients in need of highly specialised treatment Writer: Emily Jarvis • Project Manager: Eddie Clinton

igshospitalet is perceived as a modern, patient-oriented and state-of-the-art facility, highly specialised in key medical areas. As Denmark’s leading hospital, it is known as the flagship for research and development, innovation and sustainability which are at the heart of the organisation. In close collaboration with other hospitals in the capital region, and with enterprise and knowledge institutions

such as MD Anderson Cancer Centre and Copenhagen Science City, Rigshospitalet serves as a power centre for research in healthcare and medical science. Among the 10 best research hospitals in Europe, Rigshospitalet offers education and training programmes at a high level and holds the highest productivity rate among specialised hospitals on the continent. “Competent and dedicated employees who cooperate to provide the best

WWW.EUROPEOUTLOOKMAG.COM

60


R I G S H O S P I T A L E T

quality for patients is just one of our visions and goals we uphold as part of our vision 2020,” said the hospital.

Award-winning patient care

Being one of the region’s largest workplaces, with a good national and international image, Rigshospitalet attracts a wide range of employees and students from around the world, who contribute actively to developing the Copenhagen Science City North, while remaining the preferred choice for patients in need of exceptional specialised treatment. Divided into six treatment centres and two interdisciplinary centres, each centre has a number of clinics and departments, 12 of these key areas have been awarded The Global Excellence award including physiology, dementia and haematology. The award is presented based on leading results within basic research, studies and treatment, education, or clinical or translational research, which fits with the organisation’s overall vision to be internationally regarded as Denmark’s best hospital. “Treating a critically ill patient will be in the hands of many different

The Global Excellence Award Below are just some of the departments that have received The Global Excellence award over the years:

Department of Clinical Physiology and Nuclear Medicine Last year the department examined more than 30,000 patients and it produced more than 70 scientific publications and dissertations. By developing new trace elements and methods of scanning, the department is working to better prepare physicians in the struggle to combat cancer.

Danish Dementia Research Centre Denmark is the future innovative and active co-player in international work and the research centre is working to improve Denmark’s opportunities by participating in large, international solutions. In the research area, the research centre has identified new mutations of dementia diseases, and it has examined the effects of giving early psycho-social support to patients and relatives living with Alzheimer’s.

Department of Haematology The department is the largest department in Denmark within this field, and is unrivalled within new and more effective treatments targeting the cancer cell. In addition, it covers the whole spectrum from research in normal cells to research in cancer cells and testing new medicines.

61

WWW.EUROPEOUTLOOKMAG.COM

professionals and specialist groups. This requires excellent international cooperation as well as with other hospitals involved in the patient’s overall course of treatment,” stated the hospital, which has a number of external stakeholders that make a contribution to its vision 2020 goals.

New developments

Righospitalet is one of Denmark’s largest workplaces, comprising of approximately 8,000 employees broken down into more than 50 professional groups. Moreover, the hospital is one of Denmark’s largest educational institutions with medical science programmes. “A large number of staff in the rest of the Danish national healthcare system have been wholly or partly trained or further educated at Rigshospitalet,” says the hospital. As the leading Danish institution introducing new, highly specialised treatments, new development of the hospital site is essential for the betterment of international research and treatments. Back in 2008, the hospital’s departments underwent a merger and relocation


H

E

A

L

T

H

C

A

R

E

Center for Genomic Medicine:

A true Sample to Insight laboratory

“Most people I meet are surprised by the extent to which genomics has already changed healthcare”, said Professor Finn Cilius Nielsen, head of the Center for Genomic Medicine at the Rigshospitalet in Copenhagen. His laboratory, founded in 2010, has quickly evolved to be one of the world’s leading institutions in driving genomic technologies into routine clinical applications. The center runs up to 3,500 genetic tests a year, mostly on advanced next-generation sequencing (NGS) and microarray technologies. “We are applying these technologies to clinical practice more quickly than anyone anticipated,” Professor Nielsen said. Most are used to improve cancer treatments. To ensure access to the latest technologies, the center maintains close relationships with leading technology providers, including QIAGEN. The two

organizations recently entered a formal partnership that further strengthens their collaboration. The agreement is centered on QIAGEN’s “Sample to Insight” solutions for NGS, with a focus on cancer, and covers full workflows including reagents, instruments and advanced bioinformatics. The Center’s research and development programs led by Dr. Thomas van Overeem Hansen are the first to use new QIAGEN technologies. One program focuses on hereditary breast and colon cancer using QIAGEN gene panels, which require smaller tissue volumes than existing methods, a critical advantage when working with scarce tumor samples. QIAGEN technologies also enable minimally invasive liquid biopsies to monitor patient response to cancer treatments. CLC Genomics Server and Ingenuity bioinformatics solutions help to analyze the vast amounts of data produced by NGS.

“We are very happy to use QIAGEN’s NGS solutions because we know we receive good quality results,” Professor Nielsen said. Initial data obtained from the plasma of nearly 80 cancer patients who did not respond to first line treatment looks very promising, for example, and the team hopes that it can soon transfer these findings into clinical practice. “We truly are a Sample to Insight laboratory,” said Dr. Lars Jønson, head of the NGS center. “As a result, we are bringing greater understanding to a wide range of important medical issues, particularly in cancer.”

For more information on QIAGEN’s Sample to Insight solutions, please contact

William.Wright@qiagen.com or visit www.qiagen.com

WWW.EUROPEOUTLOOKMAG.COM

62


R I G S H O S P I T A L E T

to Rigshospitalet in order to extend the possibilities for expansion. “The mergers and other changes as a consequence of the hospital’s plan for the capital region of Denmark made it necessary to build a new wing and renovate the existing buildings of the hospital in order to better cater for patients’ needs,” commented the hospital. Over the next five years, Rigshospitalet will continue to utilise its partnerships and reputation as the hospital’s guiding principle up to 2020. The institution will continue as the flagship hospital for the Capital Region of Denmark, and will continue its efforts to remain the preferred choice for patients in need of highly specialised treatment. “Our world is becoming ever more connected, and this applies in the health sector too. We must learn from and cooperate with the best international hospitals in order to uphold our status as a hospital that offers the best treatment and the best research in Denmark,” concluded the hospital.

63

Introducing new, highly specialised treatments

WWW.EUROPEOUTLOOKMAG.COM


H

E

A

L

T

H

C

A

R

E

Working in close collaboration with... MD Anderson Cancer Centre On June 30 2014, Rigshospitalet established an official collaboration agreement with the largest cancer hospital in the US; the MD Anderson Cancer Centre. Officially a sister institution, Rigshospitalet is now part of a global network comprising 24 other cancer hospitals. As a result of this partnership, the hospital has also become part of the Global Academic Programme (GAP), which provides access to a global research network and thereby more rapid access to the latest technology and clinical frontline research. Research and treatment collaboration includes child cancer, radiotherapy, accelerated patient pathways, gynaecological cancer and palliative medicine.

Copenhagen Science City

Rigshospitalet is part of Copenhagen

Science City where business and knowledge institutions can create, share and utilise knowledge. As part of the Copenhagen University Hospital, Rigshospitalet participates in research and development projects at an international level and trains many thousands of health students at both pre-graduate and post-graduate levels. Together with University of Copenhagen,

the Panum Institute and the Metropolitan University College, Rigshospitalet is a significant part of Copenhagen Science City. The Science City encourages close and informal collaboration with the private sector as well as the public sector. This collaboration makes it easy for businesses to establish links to researchers, students and other companies in the area.

WWW.EUROPEOUTLOOKMAG.COM

64


RIGSHOSPITALET Blegdamsvej 9 2100 København Ø Denmark T: +45 35 45 35 45 rigshospitalet@rh.regionh.dk

www.rigshospitalet.dk

RIGSHOSPITALET  

Rigshospitalet Business Brochure - Europe Outlook Issue 6